Guangzhou, China -- (ReleaseWire) -- 09/18/2019 -- Wondfo is excited to announce that it will participate in the Medic East Africa (MEA) 2019 from September 24th to 26th at Kenyatta International Convention Centre in Nairobi (Stand No: 2C19). For these years, the discovery and breakthroughs made by Wondfo have continuously given fresh impetus to the rapid diagnostic test field.

Connecting both manufacturers and service providers with clinicians, procurement professionals, dealers and distributors, Medic East Africa serves as the influential platform to showcase advanced medical equipment and state-of-the-art medical technology on a global level. The coming Medic East Africa 2019 is a place where more than 200 professional biomedical companies and 3,000 healthcare professionals from nearly 30 countries will provide attendees with the widest range of most cost-effective and innovative medical devices, products and supplies. At the same time, more than 10,000 visitors can have the opportunity to leverage the success of this event and make key business contacts by utilizing the multiple channels and abundant resources.

Wondfo now concentrates on the Medic East Africa 2019 and plans to bring its top 4 rapid diagnostic test equipment to Kenya. Wondfo, a China-based expert in researching and developing immunofluorescence test, gold nanoparticles applications, quantitative chemical analysis, blood gas test, as well as prothrombin time test for more than 27 years, is well-known for its pursuit of the sophisticated and precise rapid diagnostic test for healthcare professionals. For several years, the business of this firm went from strength to strength. As this firm's brand power improves, the high-quality rapid diagnostic test equipment and superior services have earned Wondfo a good reputation in the healthcare industry and enabled it to sell products to the whole world. Additionally, with reliable and long-term partnerships, this firm has already established a global business network these years.

As a matter of fact, the research and development ability is now emerging to be the core of Wondfo's business running. Moreover, the persistent efforts facilitate Wondfo to launch four rapid diagnostic test devices, which gain wide attention and recognition from customers globally. The following are detailed information of top 4 healthcare equipment to be showcased by this company at Medic East Africa 2019.

Blood Gas Analyzer
Worked with original blood gas analyzer test card and blood gas analyzer reagent pack from Wondfo, this rapid diagnostic test equipment can be used to detect and record the blood pH, carbon dioxide partial pressure, oxygen partial pressure, sodium ion, potassium ion, calcium ion, chloride ion, hematocrit, Lactic Acid and Glucose. On the credit side, the process of healthcare test above by this equipment lasts only 30 seconds. Besides, equipped with a remarkable built-in battery, it can test and record the data of more than 50 samples during the outage.

Optical Coagulation Analyzer
As the first coagulation test equipment for 5 test items in China, this Optical Coagulation Analyzer can perform coagulation tests including prothrombin time, activated partial thromboplastin time, activated clotting time, thrombin time and fibrinogen with Optical Coagulation analyzer test card. Aimed at Vitro Diagnostic use, this device can present the test result in 3 minutes.

Dry Chemistry Analyzer
Actuated by original Dry Chemistry Analyzer test strip from Wondfo, this top-class rapid diagnostic test equipment brings a new generation of capabilities to diagnose conditions such as liver function, kidney function, myocardial enzyme, emergency treatment, blood routine examination, blood glucose, etc. in 5 minutes.

One Step HIV 1/2 Whole Blood/Serum/Plasma Test
Obtained the attestation of WHO Prequalified, this rapid diagnostic test device can provide the qualitative detection of not only the HIV1/2 antibodies in human whole blood, but also the serum or plasma at specified cut-off level with 100% sensitivity and 99.96% specificity.

About Wondfo
Founded in 1992, Wondfo is one of the earliest high-tech biological enterprises specializing in rapid diagnostic test in China. Equipped with research laboratories covering nearly 5,000 square meters and international leading production lines, Wondfo is good at providing a powerful production capacity and professional custom services to its clients. What's more, striving to embrace the principles of satisfactory customer services all the time, this company endeavors to offer customers comprehensive medical help and counseling in real time. In general, this firm's recent activities in the ever-changing global market have earned it a stable and broad business network these years.

Media Contact
Company Name: Wondfo
Telephone: 86-20-32051121
Address: No.8 Lizhishan Road, Science City, Luogang District, Guangzhou, China
Email: brand@wondfo.com.cn
Website: https://en.wondfo.com.cn/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Guangzhou, China -- (ReleaseWire) -- 08/20/2019 -- Wondfo, as one of the earliest high-tech biological companies focusing on rapid diagnostics in China, participated in a global laboratory medicine community, AACC this August. During August 6th to 8th, it showcased the latest techniques and products at the exhibition.

AACC Annual Scientific Meeting & Clinical Lab Expo, held in Anaheim Convention Center, Anaheim, California, USA, is an annual meeting aimed at bringing better health through laboratory medicine. This being its 71st edition, AACC Expo has carved a niche for itself in this space. It enables key professionals to showcase the best creations, discover innovative products and services, and exchange ideas in the medical industry. This year, vital research and advanced breakthrough in this field has been shown, and cutting-edge technology has been revealed. Global leaders gathered together to exchange the latest investigations. Wondfo was one of them to show their advanced technology to the world, creating a wonderful world with Wondfo POCT products.

POCT, short for Point-of-care testing, refers to clinical testing and bedside testing performed beside patients. It is not usually performed by clinical examiners. Instead, it is a kind of new method that the sample is analyzed immediately on the sampling site. The complicated processing procedure is omitted in the laboratory test, and the test results could be obtained quickly. It's with POCT that testing becomes accessible in every family caring for health. And POCT makes it possible for everyone to know their health state at anytime and anywhere.

Founded in 1992, Wondfo has specialized in R&D, manufacture, sales of POCT and its related equipment. Its products and services include immune solutions, blood gas solutions, coagulation solutions, and dry chemistry solutions. All of these products have been sold to the whole world. Apart from the Guangzhou headquarters, Wondfo owns twooverseas labs which locate in San Diego and Tokyo respectively, one branch in Chicago and other eleven overseas offices. And that's how it sweeps the global market with cutting-edge technology and high-end products.More than 20 year's accumulation will never stop Wondfo striving for excellence; instead it will prompt Wondfo to perfect its products and services to the fullest.

Wondfo has brought a sparkling show in this exhibition and gained in-depth knowledge through communicating with other companions. Their exhibition has aroused more public attention to POCT. More and more people as well as companies came to realise the importance of daily health detecting. Wondfo can be said to bring about an excellent show and changes to global health.

About Wondfo
As a globally recognized fast-growing POCT leader in China, Guangzhou Wondfo Biotech Co., Ltd has specialized in R&D, manufacture, and sales of rapid diagnostic reagents and related equipment. It has won a good reputation around the world for high-quality products and professional services. It has been certified to CE certificates, FDA certificates, FSC certificates, ISO 9001:2008 and ISO 13485:2012 quality system certification in recent years.

Media Contact
Company Name: Wondfo
Email: sales@wondfo.com.cn
Address: No.8 Lizhishan Road, Science City, Luogang District, Guangzhou, China
Website: https://en.wondfo.com.cn/

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm

Agreement in Malaria WHO PQ Strategic Cooperation

Guangzhou, China -- (ReleaseWire) -- 11/27/2018 -- The Bill & Melinda Gates Foundation found their firm ally against malaria. Guangzhou Wondfo Biotech Co., Ltd, a leading developer and manufacturer of biological technology products, has reached an agreement with the Foundation regarding solutions for a rapid diagnostic test for malaria. Both parties signed an agreement on future cooperation in the headquarter office of Wondfo.

The signing ceremony, titled "Malaria WHO PQ Strategic Cooperation", was attended by management boards members from both organizations. Mr. Alex Ng and Ms. Wendy Wei, representatives of the Foundation in China, and Ms. Linda Tao, Headquarter Representative of the Foundation, were greeted in the Wondfo headquarter office by Mr. Li Wenmei, Chinaman of Wondfo, Mr. Zhao Yaping, Rotating CEO and Mr. Zhang Yichao, Director of International Department. On the conference among these executive members, the Foundation forged a close bond with Wondfo in regard of cooperation in malaria RDT products.

Earlier this month, Wondfo presented its new products, including the latest Finecare 2Plus meter, pet testing devices and blood gas analyzers in MEDICA 2018, an industry-leading trade fair for the medical sector held in Duesseldorf, Germany. Towards top-rated medical organizations from all over the globe, Wondfo proved its capability as a world-class medical appliance solution provider. Its assertion and strength in medical testing solutions facilitated its cooperation with the foundation established by Bill Gates, the co-founder of Microsoft and his wife, Melinda Gates.

Malaria has been a major concern of the Foundation since its establishment back in 2000. They initiated a "medicines for malaria venture" to promote the discovery and development of anti-malarial drugs at prices that are affordable to the populations worst hit by the disease. Earlier in September, the Foundation granted over 12 million dollars to the African Leaders Malaria Alliance (ALMA) to maintain malaria high on the political and policy agenda at the regional and national level in ALMA member countries.

Mr. Li Wenmei, in his speech during the ceremony, expressed his resolution in confronting malaria in Africa. Meanwhile, he believed that joining hands with the Bill & Melinda Gates Foundation would help to reach malaria-suffering areas more effectively and responsively, supporting them with affordable testing materials against malaria.

Mr. Alex Ng, on behalf of the health innovation and cooperation projects of the Foundation, delivered the global operation summary of the Foundation, as well as its strategy against malaria in China and its partner network all around the globe.

Wondfo and Bill & Melinda Foundation both agreed on further cooperation to provide Africa with more economic and effective malaria testing products.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm